These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21703339)

  • 21. Effect of vitamin E TPGS on immune response to nasally delivered diphtheria toxoid loaded poly(caprolactone) microparticles.
    Somavarapu S; Pandit S; Gradassi G; Bandera M; Ravichandran E; Alpar OH
    Int J Pharm; 2005 Jul; 298(2):344-7. PubMed ID: 15967606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solid microparticles based on chitosan or methyl-β-cyclodextrin: a first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate.
    Rassu G; Soddu E; Cossu M; Brundu A; Cerri G; Marchetti N; Ferraro L; Regan RF; Giunchedi P; Gavini E; Dalpiaz A
    J Control Release; 2015 Mar; 201():68-77. PubMed ID: 25620068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Permeation-enhancing effects of chitosan formulations on recombinant hirudin-2 by nasal delivery in vitro and in vivo.
    Zhang YJ; Ma CH; Lu WL; Zhang X; Wang XL; Sun JN; Zhang Q
    Acta Pharmacol Sin; 2005 Nov; 26(11):1402-8. PubMed ID: 16225765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fabrication and evaluation of celecoxib microparticle surface modified by hydrophilic cellulose and surfactant.
    Ha ES; Ok J; Noh J; Jeong HY; Choo GH; Jung YS; Baek IH; Kim JS; Cho W; Hwang SJ; Kim MS
    Int J Biol Macromol; 2015 Jan; 72():1473-8. PubMed ID: 25451745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel polyelectrolyte complexes based on poly(methacrylic acid)-bis(2-aminopropyl)poly(ethylene glycol) for oral protein delivery.
    Sajeesh S; Sharma CP
    J Biomater Sci Polym Ed; 2007; 18(9):1125-39. PubMed ID: 17931503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.
    Mahjub R; Radmehr M; Dorkoosh FA; Ostad SN; Rafiee-Tehrani M
    Drug Dev Ind Pharm; 2014 Dec; 40(12):1645-59. PubMed ID: 24093431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations.
    Shao Z; Krishnamoorthy R; Mitra AK
    Pharm Res; 1992 Sep; 9(9):1157-63. PubMed ID: 1409397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nimodipine Ophthalmic Formulations for Management of Glaucoma.
    Maria DN; Abd-Elgawad AH; Soliman OA; El-Dahan MS; Jablonski MM
    Pharm Res; 2017 Apr; 34(4):809-824. PubMed ID: 28155073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin.
    Sajeesh S; Bouchemal K; Marsaud V; Vauthier C; Sharma CP
    J Control Release; 2010 Nov; 147(3):377-84. PubMed ID: 20727924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation of honokiol-loaded chitosan microparticles via spray-drying method intended for pulmonary delivery.
    Li X; Guo Q; Zheng X; Kong X; Shi S; Chen L; Zhao X; Wei Y; Qian Z
    Drug Deliv; 2009 Apr; 16(3):160-6. PubMed ID: 19514976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth.
    Ghosh I; Bose S; Vippagunta R; Harmon F
    Int J Pharm; 2011 May; 409(1-2):260-8. PubMed ID: 21371540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lyophilized inserts for nasal administration harboring bacteriophage selective for Staphylococcus aureus: in vitro evaluation.
    Alfadhel M; Puapermpoonsiri U; Ford SJ; McInnes FJ; van der Walle CF
    Int J Pharm; 2011 Sep; 416(1):280-7. PubMed ID: 21771648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats.
    Bshara H; Osman R; Mansour S; El-Shamy Ael-H
    Carbohydr Polym; 2014 Jan; 99():297-305. PubMed ID: 24274510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.
    Cirri M; Bragagni M; Mennini N; Mura P
    Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissolution and bioavailability of lercanidipine-hydroxypropylmethyl cellulose nanoparticles with surfactant.
    Ha ES; Choo GH; Baek IH; Kim JS; Cho W; Jung YS; Jin SE; Hwang SJ; Kim MS
    Int J Biol Macromol; 2015 Jan; 72():218-22. PubMed ID: 25159878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential use of cholecalciferol polyethylene glycol succinate as a novel pharmaceutical additive.
    Zhao HZ; Tan EC; Yung LY
    J Biomed Mater Res A; 2008 Mar; 84(4):954-64. PubMed ID: 17647225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery.
    Witschi C; Mrsny RJ
    Pharm Res; 1999 Mar; 16(3):382-90. PubMed ID: 10213368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of different absorption enhancers on the intranasal absorption of isosorbide dinitrate in rats.
    Na L; Mao S; Wang J; Sun W
    Int J Pharm; 2010 Sep; 397(1-2):59-66. PubMed ID: 20599486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles.
    Di Gioia S; Trapani A; Mandracchia D; De Giglio E; Cometa S; Mangini V; Arnesano F; Belgiovine G; Castellani S; Pace L; Lavecchia MA; Trapani G; Conese M; Puglisi G; Cassano T
    Eur J Pharm Biopharm; 2015 Aug; 94():180-93. PubMed ID: 26032293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Supercritical fluid assisted production of micrometric powders of the labile trypsin and chitosan/trypsin composite microparticles.
    Shen YB; Guan YX; Yao SJ
    Int J Pharm; 2015 Jul; 489(1-2):226-36. PubMed ID: 25957701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.